Trial Profile
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients with Hematologic Malignancies
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs TZ 101 (Primary)
- Indications Acute biphenotypic leukaemia; Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Haematological malignancies; Hodgkin's disease; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 27 Apr 2017 Status changed from active, no longer recruiting to completed.
- 10 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 03 May 2016 Status changed from active, no longer recruiting to recruiting.